Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Cancer cohort characteristics by cancer type

From: Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents

  n (%) Male (%) Age at diagnosis Time from diagnosis to death Degree of cancer spread, n (%)
Median (range) In-situ/localized Regionalized Metastatic Unknown*
Median (range)
All cancers 9,862 (100) 6,746 (68.4) 82.6 (54.5–105.6) 1.6 (0–15.8) 3,243 (32.9) 1,321 (13.4) 1,592 (16.1) 3,706 (37.6)
Prostate (C61) 1,735 (17.6) 1,735 (100) 80.8 (61.8–98.6) 5.3 (0–15.8) 586 (34.2) 53 (3.1) 150 (8.6) 943 (54.3)
Multiple cancers 1,652 (16.8) 1,322 (80.0) 83.5 (64.3–100.0) 0.9 (0–14.7) 548 (34.2) 217 (13.1) 300 (18.2) 578 (35.0)
Colorectal (C18–C21) 1,049 (10.6) 615 (58.6) 82.3 (56.8–101.7) 2.6 (0–15.7) 322 (31.7) 403 (38.4) 169 (16.1) 154 (14.7)
Lung (C33–C34) 951 (9.6) 630 (66.2) 82.6 (56.7–100.9) 0.4 (0–14.5) 202 (23.5) 131 (13.8) 294 (30.9) 311 (32.7)
Melanoma of skin (C43) 634 (6.4) 476 (78.1) 81.7 (57.8–99.3) 4.1 (0–15.8) 278 (42.7) 80 (12.6) 59 (9.3) 39 (6.2)
Haematological (C81–C96) 663 (6.7) 379 (57.2) 83.1 (60.8–102.4) 1.2 (0–14.8) 451 (72.2) 8 (1.2) 9 (1.4) 593 (89.4)
Other** 571 (5.80) 355 (62.2) 83.0 (60.8–100.3) 2.4 (0–15.1) 40 (6.4) 25 (4.4) 14 (2.4) 262 (45.9)
Breast (C50) 449 (4.6) 12 (2.7) 80.3 (54.5–105.6) 4.9 (0–15.2) 187 (41.6) 122 (27.2) 24 (5.4) 115 (25.6)
Digestive organs (C15–C17, C22–C24) 471 (4.8) 281 (59.7) 83.3 (59.8–97.1) 0.6 (0–15.7) 134 (31.6) 98 (20.8) 91 (19.3) 137 (29.1)
Unknown primary site (C26, C39, C76–C80) 389 (3.9) 209 (53.7) 85.5 (66.3–100.7) 0.1 (0–13.1) 1 (0.3) 13 (3.3) 242 (62.2) 132 (33.9)
Bladder (C67) 299 (3.0) 218 (72.9) 83.6 (64.0–98.3) 1.5 (0–15.6) 117 (40.9) 33 (11.4) 25 (8.4) 124 (41.5)
Pancreas (C25) 282 (2.9) 144 (51.1) 84.4 (67.9–97.9) 0.2 (0–7.8) 50 (20.4) 23 (8.2) 101 (35.8) 99 (35.1)
Head and neck (C00–C14, C30–C32) 226 (2.3) 176 (77.9) 81.6 (56.8–99.9) 2.9 (0–14.6) 96 (43.4) 49 (21.7) 7 (3.1) 73 (32.3)
Female genital organs (C51–C58) 183 (1.9) 0 (0) 82.3 (59.2–103.1) 1.2 (0–15.4) 52 (30.3) 38 (20.8) 54 (29.5) 39 (21.3)
Kidney (C64) 145 (1.5) 89 (61.4) 82.3 (63.3–94.9) 2.0 (0–13.6) 54 (40.6) 15 (10.3) 39 (26.9) 36 (24.8)
Connective and soft tissue (C45, C47–C49) 99 (1.0) 74 (74.7) 81.7 (64.6–95.0) 0.7 (0–13.7) 28 (29.5) 12 (12.1) 14 (14.1) 42 (42.4)
Brain (C71) 64 (0.6) 31 (48.4) 82.3 (54.6–93.4) 0.2 (0–10.6) 31 (51.7) 1 (1.6) 0 29 (45.3)
  1. *Includes clients with cancer cause of death identified in death registry data; these clients do not have a cancer diagnosis in the NSW cancer registry (and no degree of cancer spread information).
  2. **Includes C37–C39, C40–C41, C46, C60, C62, C63, C65, C66, C68, C69, C70, C72, C73–C75, D03, D05, D45, D46.0–D46.4, D46.7–D46.9, D47.1 and D47.3.